Condition
    Effectiveness 1/5

    Vinpocetine for Cognitive Decline

    Cochrane reviews of vinpocetine for both cognitive impairment and acute ischemic stroke concluded the evidence is insufficient, and the FDA has warned it may cause fetal harm.

    Overview

    Cochrane reviews of vinpocetine for both cognitive impairment and acute ischemic stroke concluded the evidence is insufficient, and the FDA has warned it may cause fetal harm.

    Verdict

    Not supported

    Weak and dated trial evidence, a synthetic drug sold outside drug regulation, and an active safety warning — the risk-benefit case does not hold.

    How It Works

    PDE1 inhibition and sodium channel blockade increase cerebral blood flow, a mechanism that has not translated into measurable cognitive benefit in controlled trials.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Not recommended
    Expected timeframe
    Not applicable

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    The verdict is no. Vinpocetine has been studied at 5-10 mg three times daily (15-30 mg/day). A Cochrane review of vinpocetine for cognitive impairment and dementia concluded the evidence was inadequate to support any benefit, and no adequately powered trial has shown it slows cognitive decline. It is a prescription drug in some countries but is sold as a supplement in others despite being a synthetic vinca alkaloid derivative, not a dietary ingredient.
    titration
    Not applicable
    starting dose
    Not applicable

    Evidence

    What the studies say

    The Cochrane review of vinpocetine for cognitive impairment and dementia identified three placebo-controlled trials totalling 583 patients, all from the 1980s, using 30-60 mg/day over three to six months. Some short-term cognitive scale improvements appeared, but the reviewers judged methods and reporting inadequate and concluded there is insufficient evidence to support routine use, calling for trials that have not since been conducted. A parallel Cochrane review in acute ischemic stroke reached the same conclusion from even sparser data. Independent product testing has found substantial deviation from labelled vinpocetine content, including products containing none. In 2019 the FDA issued a safety communication after NIH toxicology work showed reduced fetal weight and increased miscarriage in animals, advising women who could become pregnant not to take it. Vinpocetine is prescription-regulated across much of Europe for good reason.

    Effect of vinpocetine on cognitive performances of a Nigerian population

    Score: 4/10
    2014
    rct
    n=60

    Ogunrin A

    Vinpocetine improved attention and working-memory measures relative to placebo in healthy adults.

    View source

    Vinpocetine for cognitive impairment and dementia

    Score: 9/10
    2003
    meta_analysis
    n=583

    Szatmári SZ, Whitehouse PJ

    The evidence is insufficient to support the use of vinpocetine for people with dementia.

    View source

    Safety

    Caveats

    Cognitive decline must be assessed medically - reversible causes including B12 deficiency, thyroid disease, depression, sleep apnoea and medication effects should be excluded, and Alzheimer disease has licensed treatments. Vinpocetine carries a specific and serious warning: the US FDA advises that women who are or could become pregnant should not take it, because animal data show reduced fetal weight and increased miscarriage risk - treat it as contraindicated in pregnancy. Safety ceiling: above 30 mg/day is unstudied. It may add to bleeding risk with anticoagulants and antiplatelets and can lower blood pressure. It is banned in supplements in several jurisdictions.

    Less likely to help if

    Everyone: no responder group has been demonstrated, and reproductive-age women should avoid it entirely.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.